Compare

Northwest Biotherapeutics Inc vs Rani Therapeutics Holdings, Inc. vs China SXT Pharmaceuticals, Inc. vs 60 Degrees Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Northwest Biotherapeutics Inc NWBO	Rani Therapeutics Holdings, Inc. RANI	China SXT Pharmaceuticals, Inc. SXTC	60 Degrees Pharmaceuticals, Inc. SXTP
Year ended	2025-12-31	2025-12-31	2026-03-31	2025-12-31
Revenue	$1.38M	$1.63M	$1.14M	$1.01M
Revenue growth (YoY)	-0.3%	+58.9%	-34.6%	+65.5%
Gross margin	n/a	n/a	21.9%	22.3%
Operating margin	n/m	n/m	-625.9%	-771.6%
Net margin	n/m	n/m	-545.2%	-732.5%
Net income	-$60.16M	-$40.95M	-$6.21M	-$7.37M
EPS (Diluted)	-$0.04	-$0.45	-$9.13	-$11.73
Operating cash flow	-$44.76M	-$18.71M	-$4.02M	-$6.85M
Free cash flow	-$46.27M	-$18.80M	n/a	-$6.99M
Cash & equivalents	$3.04M	$18.62M	$28.18M	$1.51M
Total assets	$81.29M	$58.62M	$34.75M	$5.37M
Total liabilities	$128.86M	$17.11M	$5.05M	$1.99M
Shareholders' equity	-$60.28M	$33.01M	$29.71M	$3.46M
Return on year-end equity	n/a	-124.1%	-20.9%	-212.7%
Shares outstanding	1.56B	n/a	n/a	1.16M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Northwest Biotherapeutics Inc	Rani Therapeutics Holdings, Inc.	China SXT Pharmaceuticals, Inc.	60 Degrees Pharmaceuticals, Inc.
Latest	$1.38M Ended 2025-12-31	$1.63M Ended 2025-12-31	$1.14M Ended 2026-03-31	$1.01M Ended 2025-12-31
1 year earlier	$1.38M Ended 2024-12-31	$1.03M Ended 2024-12-31	$1.74M Ended 2025-03-31	$607.6K Ended 2024-12-31
2 years earlier	$1.93M Ended 2023-12-31	$0 Ended 2023-12-31	$1.93M Ended 2024-03-31	$253.6K Ended 2023-12-31
3 years earlier	$1.68M Ended 2022-12-31	$0 Ended 2022-12-31	$1.97M Ended 2023-03-31	$223.2K Ended 2022-12-31
4 years earlier	$1.00M Ended 2021-12-31	$2.72M Ended 2021-12-31	$2.60M Ended 2022-03-31	n/a